Attribution Statement: LactMed is a registered trademark of the U.S. Department of Health and Human Services.
NCBI Bookshelf. A service of the National Library of Medicine, National Institutes of Health.
Drugs and Lactation Database (LactMed®) [Internet]. Bethesda (MD): National Institute of Child Health and Human Development; 2006-.
CASRN: 1030377-33-3
Drug Levels and Effects
Summary of Use during Lactation
Data from two women indicate that amounts of suvorexant in milk are very low. If suvorexant is required by the mother, it is not a reason to discontinue breastfeeding. If suvorexant is used, monitor the infant for sedation, especially if the infant is a newborn or preterm. Until more data become available, an alternate drug may be preferred, especially while nursing a newborn or preterm infant.
Drug Levels
Maternal Levels. Two women were taking suvorexant 20 mg at night. They provided milk samples “a few days” after delivery. One woman provided a sample before a dose and 70 minutes after a dose. The concentrations in those samples were 1.36 and 2.85 mcg/L. The second woman provided samples a few days and one month after delivery taken at unknown times the day after taking the drug. The milk concentrations were 3.47 and 4.09 mcg/L, respectively. The authors estimated the relative infant dosages to be 0.17 and 0.2% in the two women, respectively.[1]
Infant Levels. Relevant published information was not found as of the revision date.
Effects in Breastfed Infants
Relevant published information was not found as of the revision date.
Effects on Lactation and Breastmilk
Relevant published information was not found as of the revision date.
References
- 1.
- Ishikawa H, Furugen A, Nishimura A, et al. Validated UPLC-MS/MS method for quantification of melatonin receptor agonists and dual orexin receptor antagonists in human plasma and breast milk: Application to quantify suvorexant and lemborexant in clinical samples. J Pharm Biomed Anal 2024;251:116432. [PubMed: 39180895]
Substance Identification
Substance Name
Suvorexant
CAS Registry Number
1030377-33-3
Drug Class
Breast Feeding
Lactation
Milk, Human
Hypnotics and Sedatives
Orexin Receptor Antagonists
Sleep Aids, Pharmaceutical
Disclaimer: Information presented in this database is not meant as a substitute for professional judgment. You should consult your healthcare provider for breastfeeding advice related to your particular situation. The U.S. government does not warrant or assume any liability or responsibility for the accuracy or completeness of the information on this Site.
- User and Medical Advice Disclaimer
- Drugs and Lactation Database (LactMed) - Record Format
- LactMed - Database Creation and Peer Review Process
- Fact Sheet. Drugs and Lactation Database (LactMed)
- Drugs and Lactation Database (LactMed) - Glossary
- LactMed Selected References
- Drugs and Lactation Database (LactMed) - About Dietary Supplements
- Breastfeeding Links
- PubChem SubstanceRelated PubChem Substances
- PubMedLinks to PubMed
- Review Ibrexafungerp.[Drugs and Lactation Database (...]Review Ibrexafungerp.. Drugs and Lactation Database (LactMed®). 2006
- Review Atomoxetine.[Drugs and Lactation Database (...]Review Atomoxetine.. Drugs and Lactation Database (LactMed®). 2006
- Review Zavegepant.[Drugs and Lactation Database (...]Review Zavegepant.. Drugs and Lactation Database (LactMed®). 2006
- Review Almotriptan.[Drugs and Lactation Database (...]Review Almotriptan.. Drugs and Lactation Database (LactMed®). 2006
- Review Pregabalin.[Drugs and Lactation Database (...]Review Pregabalin.. Drugs and Lactation Database (LactMed®). 2006
- Suvorexant - Drugs and Lactation Database (LactMed®)Suvorexant - Drugs and Lactation Database (LactMed®)
Your browsing activity is empty.
Activity recording is turned off.
See more...